Bacui Tech FY2025 net profit rises 45.9% to SGD 0.4 million

Reuters
02/27
<a href="https://laohu8.com/S/YYB.SI">Bacui Tech</a> FY2025 net profit rises 45.9% to SGD 0.4 million

Bacui Technologies International Ltd. (Bacui) reported FY2025 revenue of SGD 60.3 million (up 7.6%) and total profit of SGD 0.4 million (up 45.9%), with profit attributable to shareholders of SGD 0.4 million (up 47.1%). For 2H FY2025, revenue was SGD 29.3 million (down 1.4%) and total profit was SGD 0.07 million (down 69.1%). FY2025 other income was SGD 0.3 million (down 25.3%), while total expenses were SGD 59.6 million (up 6.8%); materials and consumables rose to SGD 9.4 million (up 95.2%) and employee compensation was SGD 49.2 million (down 1.0%). Bacui ended FY2025 with cash and cash equivalents of SGD 8.7 million, net assets of SGD 8.3 million, and recorded FY2025 net cash used in operating activities of SGD 1.8 million. The company said FY2025 revenue growth was mainly driven by catering outsourcing revenue of SGD 7.3 million (up 45.6%) and labour outsourcing revenue of SGD 51.7 million (up 3.3%). Looking ahead, Bacui said it will pursue geographic expansion and strategic collaborations in China, and noted preliminary steps toward drone-enabled transportation solutions for medical supplies that commenced in December 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bacui Technologies International Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: CBLE2ZF2ZB1I61YG) on February 27, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10